Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain, Postoperative 12Brain Neoplasms 8Breast Neoplasms 5Agnosia 4Thyroid Neoplasms 3Stomach Neoplasms 3Lung Neoplasms 3Emergence Delirium 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Pain 2Inflammation 2Dexmedetomidine 2Delirium 2Chronic Pain 2Thrombosis 1Supratentorial Neoplasms 1Sigmoid Neoplasms 1Sedation 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Prostatic Hyperplasia 1Postoperative Nausea and Vomiting 1Pneumoperitoneum 1Pheochromocytoma 1Opioid Consumption, Postoperative 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Dexmedetomidine 2Saline Solution 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Dexmedetomidine × Dexmedetomidine × Clear all
NCT05291364 2023-08-01

Dexmedetomidine in Splanchnic Nerve Neurolysis

Minia University

Phase NA Completed
40 enrolled

Dexmedetomidine

NCT04771637 2021-11-30

Effect of Dexmedetomidine on Perioperative Internal Environment and Rehabilitation of Patients Undergoing Gastrointestinal Malignant Tumor Resection

Yangzhou University

Phase NA Completed
140 enrolled

Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡